Parapoxviruses in combination with classical cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer
AssigneeAiCuris GmbH & Co. KG
InventorOlaf Weber
Life of this patent
Estimating the term…
Abstract
The invention relates to a method for the production of a pharmaceutical composition for treating cancer by combining Parapoxvirus ovis with at least one anticancer agent. The invention furthermore relates to a method for treating a patient afflicted with cancer comprising the administration of Parapoxvirus ovis in combination with at least one anticancer agent.
Claims12
A method for the production of a pharmaceutical composition for treating cancer, comprising the provision of Parapoxvirus ovis and at least one anti-cancer agent, and the formulation of said Parapoxvirus ovis in combination with said at least one anti-cancer agent into a pharmaceutical acceptable carrier, wherein said anti-cancer agent is a cytotoxic agent.
A method for treating a patient afflicted with cancer, comprising the step of the administration of Parapoxvirus ovis in combination with at least one anti-cancer agent, wherein said anti-cancer agent is a cytotoxic agent.
Dependencies are inferred from the claim text.